Sonay Aldırmaz1, Esra Yücel1, Ayça Kıykım2, Haluk Çokuğraş1, Necla Akçakaya1, Yıldız Camcıoğlu1. 1. Department of Pediatrics, Division of Pediatric Allergy and Immunology, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey. 2. Department of Pediatrics, Division of Pediatric Allergy and Immunology, Marmara University Faculty of Medicine, İstanbul, Turkey.
Abstract
AIM: We aimed to determine the rate of primary immune deficiency (PID) among children presenting to our immunology outpatient clinic with a history of frequent infections and with warning signs of primary immune deficiency. MATERIAL AND METHODS: The files of 232 children aged between 1 and 18 years with warning signs of primary immune deficiency who were referred to our pediatric immunology outpatient clinic with a complaint of frequent infections were selected and evaluated retrospectively. RESULTS: Thirty-six percent of the subjects were female (n=84) and 64% were male (n=148). PID was found in 72.4% (n=164). The most common diagnosis was selective IgA deficiency (26.3%, n=61). The most common diseases other than primary immune deficiency included reactive airway disease and/or atopy (34.4%, n=22), adenoid vegetation (12.3%, n=8), chronic disease (6.3%, n=4) and periodic fever, aphtous stomatitis and adenopathy (4.6%, n=3). The majortiy of the subjects (90.5%, n=210) presented with a complaint of recurrent upper respiratory tract infection. PID was found in all subjects who had bronchiectasis. The rates of the diagnoses of variable immune deficiency and Bruton agammaglubulinemia (XLA) were found to be significantly higher in the subjects who had lower respiratory tract infection, who were hospitalized because of infection and who had a history of severe infection compared to the subjects who did not have these properties (p<0.05 and p<0.01, respectively). Growth and developmental failure was found with a significantly higher rate in the patients who had a diagnosis of severe combined immune deficiency or hyper IgM compared to the other subjects (p<0.01). No difference was found in the rates of PID between the age groups, but the diagnosis of XLA increased as the age of presentation increased and this was considered an indicator which showed that patients with XLA were being diagnosed in a late period. CONCLUSIONS: It was found that the rate of diagnosis was considerably high (72.4%), when the subjects who had frequent infections were selected by the warning signs of PID.
AIM: We aimed to determine the rate of primary immune deficiency (PID) among children presenting to our immunology outpatient clinic with a history of frequent infections and with warning signs of primary immune deficiency. MATERIAL AND METHODS: The files of 232 children aged between 1 and 18 years with warning signs of primary immune deficiency who were referred to our pediatric immunology outpatient clinic with a complaint of frequent infections were selected and evaluated retrospectively. RESULTS: Thirty-six percent of the subjects were female (n=84) and 64% were male (n=148). PID was found in 72.4% (n=164). The most common diagnosis was selective IgA deficiency (26.3%, n=61). The most common diseases other than primary immune deficiency included reactive airway disease and/or atopy (34.4%, n=22), adenoid vegetation (12.3%, n=8), chronic disease (6.3%, n=4) and periodic fever, aphtous stomatitis and adenopathy (4.6%, n=3). The majortiy of the subjects (90.5%, n=210) presented with a complaint of recurrent upper respiratory tract infection. PID was found in all subjects who had bronchiectasis. The rates of the diagnoses of variable immune deficiency and Bruton agammaglubulinemia (XLA) were found to be significantly higher in the subjects who had lower respiratory tract infection, who were hospitalized because of infection and who had a history of severe infection compared to the subjects who did not have these properties (p<0.05 and p<0.01, respectively). Growth and developmental failure was found with a significantly higher rate in the patients who had a diagnosis of severe combined immune deficiency or hyper IgM compared to the other subjects (p<0.01). No difference was found in the rates of PID between the age groups, but the diagnosis of XLA increased as the age of presentation increased and this was considered an indicator which showed that patients with XLA were being diagnosed in a late period. CONCLUSIONS: It was found that the rate of diagnosis was considerably high (72.4%), when the subjects who had frequent infections were selected by the warning signs of PID.
Authors: Asghar Aghamohammadi; Maurilia Fiorini; Mostafa Moin; Nima Parvaneh; Shahram Teimourian; Mehdi Yeganeh; Francesca Goffi; Hirokazu Kanegane; Ali Akbar Amirzargar; Zahra Pourpak; Nima Rezaei; Ali Salavati; Nima Pouladi; Sina Abdollahzade; Luigi D Notarangelo; Toshio Miyawaki; Alessandro Plebani Journal: Int Arch Allergy Immunol Date: 2006-08-30 Impact factor: 2.749
Authors: Bogumiła Elbl; Bozena Birkenfeld; Jadwiga Szymanowicz; Hanna Piwowarska-Bilska; Tomasz Urasiński; Maria Listewnik; Aleksandra Gwardyś Journal: Ann Acad Med Stetin Date: 2010
Authors: Eun Sil Kim; Dongsub Kim; Yoonsun Yoon; Yiyoung Kwon; Sangwoo Park; Jihyun Kim; Kang Mo Ahn; Soomin Ahn; Yon Ho Choe; Yae-Jean Kim; Mi Jin Kim Journal: Front Immunol Date: 2021-08-12 Impact factor: 7.561
Authors: Mischa H Koenen; Madeleen Bosma; Udo A Roorda; Fabiënne My Wopereis; Anja Roos; Erhard van der Vries; Debby Bogaert; Elisabeth Am Sanders; Marianne Boes; Jojanneke Heidema; Joris M van Montfrans; Walter Af Balemans; Thijs C van Holten; Lilly M Verhagen Journal: Clin Transl Immunology Date: 2021-10-29